Efficacy and safety of bilastine <i>vs.</i> levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial
作者全名：Chen, Xue; Han, Xiuping; Cheng, Bo; Li, Hui; Liu, Lingling; Geng, Songmei; Li, Linfeng; Li, Jie; Guo, Qing; Zhang, Guoyi; Fang, Hong; Zhang, Jianzhong
作者地址：[Chen, Xue; Zhang, Jianzhong] Peking Univ, Peoples Hosp, Dept Dermatol, Beijing 100044, Peoples R China; [Han, Xiuping] China Med Univ, Shengjing Hosp, Dept Dermatol, Shenyang 110055, Liaoning, Peoples R China; [Cheng, Bo] Fujian Med Univ, Affiliated Hosp 1, Dept Dermatol, Fuzhou 350004, Fujian, Peoples R China; [Li, Hui] Chongqing Med Univ, Affiliated Hosp 1, Dept Dermatol, Chongqing 400016, Peoples R China; [Liu, Lingling] Peking Univ First Hosp, Dept Dermatol, Beijing 100034, Peoples R China; [Geng, Songmei] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Dermatol, Xibei Hosp, Xian 710006, Shaanxi, Peoples R China; [Li, Linfeng] Capital Med Univ, Beijing Friendship Hosp, Dept Dermatol, Beijing 100050, Peoples R China; [Li, Jie] Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha 410008, Hunan, Peoples R China; [Guo, Qing] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou 510120, Guangdong, Peoples R China; [Zhang, Guoyi] Chinese Acad Med Sci, Hosp Skin Dis, Dept Dermatol, Nanjing 210042, Jiangsu, Peoples R China; [Fang, Hong] Zhejiang Univ, Coll Med, Dept Dermatol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
通信作者：Zhang, JZ (通讯作者)，Peking Univ, Peoples Hosp, Dept Dermatol, Beijing 100044, Peoples R China.
来源：CHINESE MEDICAL JOURNAL
ESI学科分类：CLINICAL MEDICINE
WOS号：WOS:001250895900007
JCR分区：Q1
影响因子：7.5
年份：2024
卷号：137
期号：12
开始页：1480
结束页：1482
文献类型：Letter
关键词：
摘要：
基金机构：Menarini China; IQVIA; MedSci
基金资助正文：This study was sponsored by Menarini China. The authors would like to thank Menarini for sponsoring this phase III study IQVIA for providing CRO services and MedSci for medical writing services. In addition, we would like to thank all the staff from 18 hospitals who participated in this study.
